InspireMD Inc (NSPR): Market Cap to Revenue
InspireMD, Inc. (NSPR) is developing the unique MicroNet vascular protection system, which creates a high level of clinic dependency on its technologies. The current P/S multiple reflects the asset's valuation dynamics, where 3.30 determines this specific parameter level. A stable staff of biomedical engineers and targeted hiring in the US guarantee the continued development of R&D. Flawless air delivery of consumables ensures that operating rooms remain fully equipped.
Analytical breakdowns for InspireMD Corp (NSPR)
InspireMD, Inc. (NSPR) creates a sustainable competitive advantage in the vascular treatment segment through its unique cardiology stents. The price-to-sales ratio reflects the market valuation of this niche expansion. This metric compares total market capitalization to annual revenue, determining the cost of every dollar of generated sales. Analyzing this ratio allows investors to identify whether the asset is overvalued or possesses growth potential as production scales.
